{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "e4d28688",
   "metadata": {},
   "outputs": [],
   "source": [
    "#from fastapi import FastAPI, UploadFile, File, Form\n",
    "import os\n",
    "import json\n",
    "import promptManager\n",
    "import outputFormating\n",
    "import pandas as pd\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "0bb2ae86",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Selected product:  TOTAL30\n"
     ]
    }
   ],
   "source": [
    "\n",
    "#Get marketing material\n",
    "marketing_material = input(\"Enter marketing material: \") \n",
    "\n",
    "# Select product - as you add more products it would be better to start using IDs but we are using names for ease of reading here.\n",
    "product=None\n",
    "while product is None:\n",
    "    product_num=input(\"1: Clareon® Toric Intraocular Lens (IOL) or 2:  PRECISION7® Contact Lenses\")\n",
    "\n",
    "    if product_num==\"1\":\n",
    "        product=\"ClareonPanOptix\"\n",
    "\n",
    "    elif product_num==\"2\":\n",
    "        product=\"TOTAL30\"\n",
    "    else:\n",
    "        print(\"Invalid input, please enter 1 or 2.\")\n",
    "    \n",
    "    print(\"Selected product: \", product)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "9120105e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Prompt built:  You are a compliance grader evaluating medical marketing content in the U.S.\n",
      "\n",
      "Your goal is to:\n",
      "1) Reward similarity with approved claims.\n",
      "2) Penalize conflicts with FDA + FTC requirements.\n",
      "3) Return structured JSON referencing policy IDs.\n",
      "\n",
      "---\n",
      "\n",
      "## Marketing Text\n",
      "good for eyes\n",
      "\n",
      "---\n",
      "\n",
      "## Policy Groups\n",
      "\n",
      "Approved Claims (positive alignment)\n",
      "- (approved:0) TOTAL30® contact lenses that feel like nothing, even at day 30.\n",
      "- (approved:1) The first and only monthly replacement Water Gradient contact lenses.\n",
      "- (approved:2) TOTAL30® contact lenses feature a gradual transition in water content, from 55 % at the core to nearly 100 % water at the outermost surface.\n",
      "- (approved:3) Water Gradient Technology in TOTAL30 contact lenses lasts for a full 30 days.\n",
      "- (approved:4) CELLIGENT® Technology creates a dynamic lens surface that biomimics the corneal surface.\n",
      "- (approved:5) Helps resist the adherence of bacteria and lipids for a clean lens.\n",
      "- (approved:6) Water Gradient delivers superior softness and superior lubricity vs. leading reusable lenses.\n",
      "- (approved:7) Class 1 UV Blocking delivers the highest level of UV protection available in a monthly replacement lens.\n",
      "- (approved:8) The first and only monthly replacement Water Gradient toric contact lenses.\n",
      "- (approved:9) TOTAL30 delivers the only Water Gradient, reusable lens that is clinically shown to feel like nothing, even on day 30.\n",
      "\n",
      "\n",
      "FDA Policies\n",
      "- (fda:0) 21 CFR § 886.5925(a): A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage.\n",
      "- (fda:1) 21 CFR § 886.5925(b)(1)-(2): Classification—Class II if intended for daily wear only; Class III if intended for extended wear.\n",
      "- (fda:2) 21 CFR § 886.5925(c): As of May 28, 1976, a PMA under section 515 of the act is required before a device described in paragraph (b)(2) may be commercially distributed.\n",
      "- (fda:3) 21 CFR § 886.1(a): This part sets forth the classification of ophthalmic devices intended for human use that are in commercial distribution.\n",
      "- (fda:4) 21 CFR § 801.1(a): The label of a device in package form shall specify conspicuously the name and place of business of the manufacturer, packer, or distributor.\n",
      "- (fda:5) 21 CFR § 801.3: Definitions—includes, among others, Automatic identification and data capture (AIDC) and other UDI-related terms.\n",
      "- (fda:6) 21 CFR § 801.5: Adequate directions for use means directions under which the layman can use a device safely and for the purposes for which it is intended.\n",
      "- (fda:7) 21 CFR § 801.15(a): Required label information must have the prominence and conspicuousness required by section 502(c) of the act.\n",
      "- (fda:8) 21 CFR § 801.18(a): Dates on device labels must be presented as YYYY-MM-DD (e.g., 2014-01-02).\n",
      "- (fda:9) 21 CFR § 801.109(c)-(d): Prescription devices—labeling in or on the dispensing package shall bear information for use, including indications, hazards, contraindications, side effects, and precautions; any distributed labeling must contain adequate information for such use.\n",
      "- (fda:10) 21 CFR § 801.20(a)(1)-(2): The label of every medical device and every device package shall bear a unique device identifier (UDI) meeting this subpart and Part 830.\n",
      "- (fda:11) 21 CFR § 801.45(a): A device required to bear a UDI on its label must also bear a permanent UDI marking on the device itself if intended to be used more than once and reprocessed before each use.\n",
      "- (fda:12) 21 CFR Part 830 (e.g., § 830.3): Establishes UDI system definitions, including AIDC and other terms used for device identification.\n",
      "- (fda:13) 21 CFR § 830.310: GUDID data submission—labeler must provide specified identifying information for each version or model required to bear a UDI.\n",
      "- (fda:14) FDA UDI Compliance Dates: Labels and packages of Class II devices must bear a UDI; dates must follow § 801.18; data must be submitted to GUDID as specified.\n",
      "- (fda:15) 21 CFR § 807.81: When a premarket notification submission is required.\n",
      "- (fda:16) 21 CFR § 807.87: Information required in a premarket notification (510(k)) submission.\n",
      "- (fda:17) 21 CFR § 807.92: Content and format of a 510(k) summary.\n",
      "- (fda:18) 21 CFR § 807.97: Misbranding by reference to premarket notification.\n",
      "- (fda:19) 21 CFR § 803.50(a): Manufacturer reporting—must report to FDA no later than 30 calendar days after becoming aware of information suggesting a device may have caused or contributed to a death or serious injury, or has malfunctioned as specified.\n",
      "- (fda:20) 21 CFR § 803.18(a): User facilities, importers, and manufacturers must establish and maintain MDR event files.\n",
      "- (fda:21) 21 CFR Part 806 (§ 806.1): Manufacturers and importers must report certain device corrections and removals and maintain records of all corrections and removals.\n",
      "- (fda:22) 21 CFR § 800.10(a)(1): All preparations intended for ophthalmic use, including contact lens solutions, should be sterile.\n",
      "- (fda:23) 21 CFR § 800.12: Contact lens solutions and tablets; tamper-resistant packaging requirements.\n",
      "\n",
      "\n",
      "FTC Policies\n",
      "- (ftc:0) § 315.1: This part, which shall be called the “Contact Lens Rule,” implements the Fairness to Contact Lens Consumers Act, codified at 15 U.S.C. 7601–7610.\n",
      "- (ftc:1) § 315.2: “Business hours” means the prescriber’s regular hours of business; “Direct communication” means completed communication by telephone, facsimile, or electronic mail.\n",
      "- (ftc:2) § 315.2: “Contact lens prescription” means a prescription, issued in accordance with State and Federal law, that contains the patient’s name, the date of examination, issue date, lens power, material or manufacturer, base curve or appropriate designation, and diameter when appropriate, and the prescriber’s name, contact information, and signature.\n",
      "- (ftc:3) § 315.3(a)(1): When a prescriber completes a contact lens fitting, the prescriber, whether or not requested by the patient, shall provide to the patient a copy of the contact lens prescription.\n",
      "- (ftc:4) § 315.3(a)(2)-(3): The prescriber shall, as directed by any person designated to act on behalf of the patient, verify the contact lens prescription by electronic or other means; and upon request, provide any person designated to act on behalf of the patient with a copy within forty (40) business hours of receipt of the request.\n",
      "- (ftc:5) § 315.3(b): A prescriber may not require the purchase of contact lenses, require additional payment, or require a waiver as a condition of providing or verifying a prescription.\n",
      "- (ftc:6) § 315.3(c)(1): Upon completion of a fitting, the prescriber shall request that the patient confirm receipt of the prescription using one of the methods specified or retain evidence of delivery if a digital copy was provided.\n",
      "- (ftc:7) § 315.3(c)(3): A prescriber must maintain for a period of not less than three years a copy of the signed confirmation, a copy of the digital prescription, or documentation of delivery.\n",
      "- (ftc:8) § 315.4: A prescriber may require payment before releasing a prescription only if immediate payment is required for an examination that reveals no need for ophthalmic goods; proof of insurance constitutes payment.\n",
      "- (ftc:9) § 315.5(a): A seller may sell contact lenses only in accordance with a prescription presented by the patient or prescriber, or verified by direct communication.\n",
      "- (ftc:10) § 315.5(b): For verification, a seller shall provide the prescriber with the patient’s full name and address, lens specifications, quantity ordered, date of request, verification date/time, and a contact person for the seller.\n",
      "- (ftc:11) § 315.5(c)(3): Passive verification—prescription is verified if the prescriber fails to communicate with the seller within eight business hours after receiving the request.\n",
      "- (ftc:12) § 315.5(d): Automated telephone verification must identify the call as a verification request, deliver the information in a slow and deliberate manner, be audible and comprehensible, and allow repetition at the prescriber’s option.\n",
      "- (ftc:13) § 315.5(e)-(f): If informed a prescription is inaccurate, expired, or otherwise invalid, the seller shall not fill it; a seller may not alter a prescription.\n",
      "- (ftc:14) § 315.6(a): A contact lens prescription shall expire on the date specified by State law if one year or more after issue; otherwise, the prescription shall expire not less than one year after issue, unless a shorter period is medically justified and documented.\n",
      "- (ftc:15) § 315.7: No person may represent, by advertisement, sales presentation, or otherwise, that contact lenses may be obtained without a prescription.\n",
      "- (ftc:16) § 315.8: A prescriber may not require a patient to sign a waiver or release as a condition of verifying or releasing a prescription or as a condition of any eye examination.\n",
      "- (ftc:17) § 315.9: Any violation of this Rule shall be treated as a violation of a rule under section 18 of the FTC Act regarding unfair or deceptive acts or practices.\n",
      "- (ftc:18) § 255.1(a): Endorsements must reflect the honest opinions, findings, beliefs, or experience of the endorser, and may not convey any representation that would be deceptive or could not be substantiated.\n",
      "- (ftc:19) § 255.2(b): If the advertiser does not have substantiation that the endorser’s experience represents what consumers will generally achieve, the advertisement must clearly and conspicuously disclose the generally expected performance in the depicted circumstances.\n",
      "- (ftc:20) § 255.3(a): Expert endorsements must be supported by an actual exercise of expertise, examination or testing conducted by the expert, and must compare products only on the basis of such expertise.\n",
      "- (ftc:21) § 255.4: Organizational endorsements shall be reached by a process adequate to ensure that the endorsement fairly represents the collective judgment of the organization.\n",
      "- (ftc:22) § 255.5: When there exists a connection between the endorser and the seller that might materially affect the weight or credibility of the endorsement, such connection must be clearly and conspicuously disclosed.\n",
      "- (ftc:23) § 255.6: Endorsements directed to children are of special concern and will be evaluated from the perspective of children.\n",
      "- (ftc:24) 15 U.S.C. § 45(a)(1): Unfair methods of competition in or affecting commerce, and unfair or deceptive acts or practices in or affecting commerce, are hereby declared unlawful.\n",
      "- (ftc:25) 15 U.S.C. § 52(a): It shall be unlawful for any person, partnership, or corporation to disseminate, or cause to be disseminated, any false advertisement for the purpose of inducing, or which is likely to induce, directly or indirectly, the purchase of food, drugs, devices, services, or cosmetics.\n",
      "- (ftc:26) 15 U.S.C. § 55(a)(1): The term “false advertisement” means an advertisement, other than labeling, which is misleading in a material respect; in determining whether an advertisement is misleading, there shall be taken into account representations made or suggested and the extent to which the advertisement fails to reveal facts material in light of such representations.\n",
      "- (ftc:27) 15 U.S.C. § 7601: Availability of contact lens prescriptions to patients—prescribers shall provide to the patient a copy of the contact lens prescription upon completion of a contact lens fitting.\n",
      "- (ftc:28) 15 U.S.C. § 7603: Prescriber verification—sellers may dispense contact lenses only in accordance with a contact lens prescription that is presented or has been verified by the prescriber.\n",
      "- (ftc:29) 15 U.S.C. § 7605: Content of advertisements and other representations—prohibits representing that contact lenses may be obtained without a prescription.\n",
      "\n",
      "\n",
      "---\n",
      "\n",
      "## Scoring Rules\n",
      "\n",
      "### Approved Claims\n",
      "If text is similar in meaning to an approved claim → high score.\n",
      "- Very similar wording → 85–100\n",
      "- Same meaning (rephrased) → 70–85\n",
      "- Partial alignment → 50–70\n",
      "- Unrelated → 0–50\n",
      "\n",
      "### FDA / FTC Policies\n",
      "Must be followed.\n",
      "Conflicts → lower score.\n",
      "\n",
      "---\n",
      "\n",
      "## Output Rules\n",
      "- You must evaluate EVERY policy in ALL policy groups (Approved, FDA, FTC). No exceptions.\n",
      "- Produce exactly one evaluation object per policy.\n",
      "- If the policy is unrelated, still output it with a high grade (e.g., 80–100) and reason \"Unrelated; no conflict.\"\n",
      "- Include: policy_id, policy, type, grade, reason.\n",
      "- Higher scores = stronger compliance.\n",
      "- Return ONLY JSON in the required format.\n",
      "- Do NOT include any text outside the JSON structure.\n",
      "\n",
      "Return ONLY JSON, no commentary.\n",
      "\n",
      "### Output JSON format\n",
      "{\n",
      "  \"evaluations\": [\n",
      "    {\n",
      "      \"policy_id\": \"<approved:3 | fda:7 | ftc:5>\",\n",
      "      \"policy\": \"<policy text>\",\n",
      "      \"type\": \"<approved | fda | ftc>\",\n",
      "      \"grade\": <0-100>,\n",
      "      \"reason\": \"<brief justification>\"\n",
      "    }\n",
      "  ],\n",
      "  \"overall_summary\": \"<short summary>\"\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "prompt=promptManager.buildPrompt(marketing_material, product)\n",
    "print(\"Prompt built: \", prompt)\n",
    "\n",
    "#Get response from LLM\n",
    "output=promptManager.getResponseFromLLM(prompt)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "9b1de050",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Output from LLM:  {'evaluations': [{'policy_id': 'approved:0', 'policy': 'TOTAL30® contact lenses that feel like nothing, even at day\\u202f30.', 'type': 'approved', 'grade': 20, 'reason': \"Text 'good for eyes' is too vague and does not convey same meaning or detail.\"}, {'policy_id': 'approved:1', 'policy': 'The first and only monthly replacement Water Gradient contact lenses.', 'type': 'approved', 'grade': 20, 'reason': 'No mention of product uniqueness or monthly replacement in text.'}, {'policy_id': 'approved:2', 'policy': 'TOTAL30® contact lenses feature a gradual transition in water content, from 55\\u202f% at the core to nearly 100\\u202f% water at the outermost surface.', 'type': 'approved', 'grade': 20, 'reason': 'Text does not reference technical lens features or water content.'}, {'policy_id': 'approved:3', 'policy': 'Water Gradient Technology in TOTAL30 contact lenses lasts for a full 30 days.', 'type': 'approved', 'grade': 20, 'reason': 'No connection to technology durability or duration in text.'}, {'policy_id': 'approved:4', 'policy': 'CELLIGENT® Technology creates a dynamic lens surface that biomimics the corneal surface.', 'type': 'approved', 'grade': 20, 'reason': 'Text does not reference CELLIGENT technology or biomimicry.'}, {'policy_id': 'approved:5', 'policy': 'Helps resist the adherence of bacteria and lipids for a clean lens.', 'type': 'approved', 'grade': 20, 'reason': 'Text does not claim bacterial or lipid resistance.'}, {'policy_id': 'approved:6', 'policy': 'Water Gradient delivers superior softness and superior lubricity vs. leading reusable lenses.', 'type': 'approved', 'grade': 20, 'reason': 'Text does not compare softness or lubricity to other lenses.'}, {'policy_id': 'approved:7', 'policy': 'Class\\u202f1\\u202fUV Blocking delivers the highest level of UV protection available in a monthly replacement lens.', 'type': 'approved', 'grade': 20, 'reason': 'No mention of UV blocking properties.'}, {'policy_id': 'approved:8', 'policy': 'The first and only monthly replacement Water Gradient toric contact lenses.', 'type': 'approved', 'grade': 20, 'reason': 'No mention of toric variant or uniqueness.'}, {'policy_id': 'approved:9', 'policy': 'TOTAL30 delivers the only Water Gradient, reusable lens that is clinically shown to feel like nothing, even on day\\u202f30.', 'type': 'approved', 'grade': 20, 'reason': \"The text 'good for eyes' is too generic and does not imply clinical results or feeling like 'nothing'.\"}, {'policy_id': 'fda:0', 'policy': '21 CFR § 886.5925(a): A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no conflict with vague marketing phrase.'}, {'policy_id': 'fda:1', 'policy': '21 CFR § 886.5925(b)(1)-(2): Classification—Class II if intended for daily wear only; Class III if intended for extended wear.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; marketing text does not address classification or wear duration.'}, {'policy_id': 'fda:2', 'policy': '21 CFR § 886.5925(c): As of May 28, 1976, a PMA under section 515 of the act is required before a device described in paragraph (b)(2) may be commercially distributed.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; the text does not mention PMA or distribution.'}, {'policy_id': 'fda:3', 'policy': '21 CFR § 886.1(a): This part sets forth the classification of ophthalmic devices intended for human use that are in commercial distribution.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; marketing text does not address classification.'}, {'policy_id': 'fda:4', 'policy': '21 CFR § 801.1(a): The label of a device in package form shall specify conspicuously the name and place of business of the manufacturer, packer, or distributor.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; does not address packaging or labeling.'}, {'policy_id': 'fda:5', 'policy': '21 CFR § 801.3: Definitions—includes, among others, Automatic identification and data capture (AIDC) and other UDI-related terms.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no reference to UDI or device identification.'}, {'policy_id': 'fda:6', 'policy': '21 CFR § 801.5: Adequate directions for use means directions under which the layman can use a device safely and for the purposes for which it is intended.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; vague claim does not provide directions.'}, {'policy_id': 'fda:7', 'policy': '21 CFR § 801.15(a): Required label information must have the prominence and conspicuousness required by section 502(c) of the act.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; marketing text does not discuss labeling.'}, {'policy_id': 'fda:8', 'policy': '21 CFR § 801.18(a): Dates on device labels must be presented as YYYY-MM-DD (e.g., 2014-01-02).', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no mention of dates.'}, {'policy_id': 'fda:9', 'policy': '21 CFR § 801.109(c)-(d): Prescription devices—labeling in or on the dispensing package shall bear information for use, including indications, hazards, contraindications, side effects, and precautions; any distributed labeling must contain adequate information for such use.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; text is a generic claim without labeling or prescription details.'}, {'policy_id': 'fda:10', 'policy': '21 CFR § 801.20(a)(1)-(2): The label of every medical device and every device package shall bear a unique device identifier (UDI) meeting this subpart and Part 830.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; does not address UDI requirements.'}, {'policy_id': 'fda:11', 'policy': '21 CFR § 801.45(a): A device required to bear a UDI on its label must also bear a permanent UDI marking on the device itself if intended to be used more than once and reprocessed before each use.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no UDI or reuse detailed.'}, {'policy_id': 'fda:12', 'policy': '21 CFR Part 830 (e.g., § 830.3): Establishes UDI system definitions, including AIDC and other terms used for device identification.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no device identification content.'}, {'policy_id': 'fda:13', 'policy': '21 CFR § 830.310: GUDID data submission—labeler must provide specified identifying information for each version or model required to bear a UDI.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; marketing text does not address database submission.'}, {'policy_id': 'fda:14', 'policy': 'FDA UDI Compliance Dates: Labels and packages of Class II devices must bear a UDI; dates must follow § 801.18; data must be submitted to GUDID as specified.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no reference to label compliance.'}, {'policy_id': 'fda:15', 'policy': '21 CFR § 807.81: When a premarket notification submission is required.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; not discussing submissions.'}, {'policy_id': 'fda:16', 'policy': '21 CFR § 807.87: Information required in a premarket notification (510(k)) submission.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no 510(k) information presented.'}, {'policy_id': 'fda:17', 'policy': '21 CFR § 807.92: Content and format of a 510(k) summary.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no 510(k) summary content.'}, {'policy_id': 'fda:18', 'policy': '21 CFR § 807.97: Misbranding by reference to premarket notification.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no misbranding or reference to PMA submission.'}, {'policy_id': 'fda:19', 'policy': '21 CFR § 803.50(a): Manufacturer reporting—must report to FDA no later than 30 calendar days after becoming aware of information suggesting a device may have caused or contributed to a death or serious injury, or has malfunctioned as specified.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no reporting required.'}, {'policy_id': 'fda:20', 'policy': '21 CFR § 803.18(a): User facilities, importers, and manufacturers must establish and maintain MDR event files.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no MDR event file content.'}, {'policy_id': 'fda:21', 'policy': '21 CFR Part 806 (§ 806.1): Manufacturers and importers must report certain device corrections and removals and maintain records of all corrections and removals.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no correction or removal info.'}, {'policy_id': 'fda:22', 'policy': '21 CFR § 800.10(a)(1): All preparations intended for ophthalmic use, including contact lens solutions, should be sterile.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; no mention of solutions or preparations.'}, {'policy_id': 'fda:23', 'policy': '21 CFR § 800.12: Contact lens solutions and tablets; tamper-resistant packaging requirements.', 'type': 'fda', 'grade': 90, 'reason': 'Unrelated; text does not discuss packaging or solutions.'}, {'policy_id': 'ftc:0', 'policy': '§ 315.1: This part, which shall be called the “Contact Lens Rule,” implements the Fairness to Contact Lens Consumers Act, codified at 15 U.S.C. 7601–7610.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; marketing text does not address consumer fairness or prescription rules.'}, {'policy_id': 'ftc:1', 'policy': '§ 315.2: “Business hours” means the prescriber’s regular hours of business; “Direct communication” means completed communication by telephone, facsimile, or electronic mail.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no references to business hours or communications.'}, {'policy_id': 'ftc:2', 'policy': '§ 315.2: “Contact lens prescription” means a prescription, issued in accordance with State and Federal law, that contains the patient’s name, the date of examination, issue date, lens power, material or manufacturer, base curve or appropriate designation, and diameter when appropriate, and the prescriber’s name, contact information, and signature.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; text does not mention prescriptions.'}, {'policy_id': 'ftc:3', 'policy': '§ 315.3(a)(1): When a prescriber completes a contact lens fitting, the prescriber, whether or not requested by the patient, shall provide to the patient a copy of the contact lens prescription.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no prescription or fitting process referenced.'}, {'policy_id': 'ftc:4', 'policy': '§ 315.3(a)(2)-(3): The prescriber shall, as directed by any person designated to act on behalf of the patient, verify the contact lens prescription by electronic or other means; and upon request, provide any person designated to act on behalf of the patient with a copy within forty (40) business hours of receipt of the request.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no verification process mentioned.'}, {'policy_id': 'ftc:5', 'policy': '§ 315.3(b): A prescriber may not require the purchase of contact lenses, require additional payment, or require a waiver as a condition of providing or verifying a prescription.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no conditional purchasing or verification mentioned.'}, {'policy_id': 'ftc:6', 'policy': '§ 315.3(c)(1): Upon completion of a fitting, the prescriber shall request that the patient confirm receipt of the prescription using one of the methods specified or retain evidence of delivery if a digital copy was provided.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no fitting completion or patient confirmation.'}, {'policy_id': 'ftc:7', 'policy': '§ 315.3(c)(3): A prescriber must maintain for a period of not less than three years a copy of the signed confirmation, a copy of the digital prescription, or documentation of delivery.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no mention of record retention or confirmation.'}, {'policy_id': 'ftc:8', 'policy': '§ 315.4: A prescriber may require payment before releasing a prescription only if immediate payment is required for an examination that reveals no need for ophthalmic goods; proof of insurance constitutes payment.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no payment or prescription release mentioned.'}, {'policy_id': 'ftc:9', 'policy': '§ 315.5(a): A seller may sell contact lenses only in accordance with a prescription presented by the patient or prescriber, or verified by direct communication.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no sales or prescription verification claims.'}, {'policy_id': 'ftc:10', 'policy': '§ 315.5(b): For verification, a seller shall provide the prescriber with the patient’s full name and address, lens specifications, quantity ordered, date of request, verification date/time, and a contact person for the seller.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; does not address verification protocols.'}, {'policy_id': 'ftc:11', 'policy': '§ 315.5(c)(3): Passive verification—prescription is verified if the prescriber fails to communicate with the seller within eight business hours after receiving the request.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no prescription timing or verification.'}, {'policy_id': 'ftc:12', 'policy': '§ 315.5(d): Automated telephone verification must identify the call as a verification request, deliver the information in a slow and deliberate manner, be audible and comprehensible, and allow repetition at the prescriber’s option.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no call or verification described.'}, {'policy_id': 'ftc:13', 'policy': '§ 315.5(e)-(f): If informed a prescription is inaccurate, expired, or otherwise invalid, the seller shall not fill it; a seller may not alter a prescription.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no prescription validity addressed.'}, {'policy_id': 'ftc:14', 'policy': '§ 315.6(a): A contact lens prescription shall expire on the date specified by State law if one year or more after issue; otherwise, the prescription shall expire not less than one year after issue, unless a shorter period is medically justified and documented.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no prescription expiration mentioned.'}, {'policy_id': 'ftc:15', 'policy': '§ 315.7: No person may represent, by advertisement, sales presentation, or otherwise, that contact lenses may be obtained without a prescription.', 'type': 'ftc', 'grade': 95, 'reason': 'Text does not claim contact lenses can be obtained without prescription; complies with rule.'}, {'policy_id': 'ftc:16', 'policy': '§ 315.8: A prescriber may not require a patient to sign a waiver or release as a condition of verifying or releasing a prescription or as a condition of any eye examination.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; marketing text does not address waivers or verification.'}, {'policy_id': 'ftc:17', 'policy': '§ 315.9: Any violation of this Rule shall be treated as a violation of a rule under section 18 of the FTC Act regarding unfair or deceptive acts or practices.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; not deceptive or unfair.'}, {'policy_id': 'ftc:18', 'policy': '§ 255.1(a): Endorsements must reflect the honest opinions, findings, beliefs, or experience of the endorser, and may not convey any representation that would be deceptive or could not be substantiated.', 'type': 'ftc', 'grade': 70, 'reason': 'Text is a vague, non-specific claim; lacks substantiation but not obviously deceptive.'}, {'policy_id': 'ftc:19', 'policy': '§ 255.2(b): If the advertiser does not have substantiation that the endorser’s experience represents what consumers will generally achieve, the advertisement must clearly and conspicuously disclose the generally expected performance in the depicted circumstances.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no endorsement or consumer expectation claims.'}, {'policy_id': 'ftc:20', 'policy': '§ 255.3(a): Expert endorsements must be supported by an actual exercise of expertise, examination or testing conducted by the expert, and must compare products only on the basis of such expertise.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no expert endorsements.'}, {'policy_id': 'ftc:21', 'policy': '§ 255.4: Organizational endorsements shall be reached by a process adequate to ensure that the endorsement fairly represents the collective judgment of the organization.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no organizational endorsements.'}, {'policy_id': 'ftc:22', 'policy': '§ 255.5: When there exists a connection between the endorser and the seller that might materially affect the weight or credibility of the endorsement, such connection must be clearly and conspicuously disclosed.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no endorsements or connections.'}, {'policy_id': 'ftc:23', 'policy': '§ 255.6: Endorsements directed to children are of special concern and will be evaluated from the perspective of children.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no endorsements directed to children.'}, {'policy_id': 'ftc:24', 'policy': '15 U.S.C. § 45(a)(1): Unfair methods of competition in or affecting commerce, and unfair or deceptive acts or practices in or affecting commerce, are hereby declared unlawful.', 'type': 'ftc', 'grade': 75, 'reason': \"Vague claim 'good for eyes' is not obviously deceptive but is unsupported and could mislead.\"}, {'policy_id': 'ftc:25', 'policy': '15 U.S.C. § 52(a): It shall be unlawful for any person, partnership, or corporation to disseminate, or cause to be disseminated, any false advertisement for the purpose of inducing, or which is likely to induce, directly or indirectly, the purchase of food, drugs, devices, services, or cosmetics.', 'type': 'ftc', 'grade': 75, 'reason': \"Text 'good for eyes' could imply a health benefit without substantiation, raising risk of false advertising.\"}, {'policy_id': 'ftc:26', 'policy': '15 U.S.C. § 55(a)(1): The term “false advertisement” means an advertisement, other than labeling, which is misleading in a material respect; in determining whether an advertisement is misleading, there shall be taken into account representations made or suggested and the extent to which the advertisement fails to reveal facts material in light of such representations.', 'type': 'ftc', 'grade': 75, 'reason': 'Claim is vague but could mislead consumers without material facts; no disclaimers provided.'}, {'policy_id': 'ftc:27', 'policy': '15 U.S.C. § 7601: Availability of contact lens prescriptions to patients—prescribers shall provide to the patient a copy of the contact lens prescription upon completion of a contact lens fitting.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; marketing text has no mention of prescription availability.'}, {'policy_id': 'ftc:28', 'policy': '15 U.S.C. § 7603: Prescriber verification—sellers may dispense contact lenses only in accordance with a contact lens prescription that is presented or has been verified by the prescriber.', 'type': 'ftc', 'grade': 90, 'reason': 'Unrelated; no mention of dispensing or verification.'}, {'policy_id': 'ftc:29', 'policy': '15 U.S.C. § 7605: Content of advertisements and other representations—prohibits representing that contact lenses may be obtained without a prescription.', 'type': 'ftc', 'grade': 95, 'reason': 'Text does not imply obtaining lenses without prescription; no conflict.'}], 'overall_summary': \"The marketing text 'good for eyes' is a vague and unspecific claim with no direct alignment to approved claims. It poses a minor risk of being considered misleading due to lack of substantiation but does not explicitly violate FDA or FTC prescription and labeling requirements.\"}\n"
     ]
    }
   ],
   "source": [
    "print(\"Output from LLM: \", output)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "183a98cb",
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "df = pd.DataFrame(output['evaluations'])\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "e20ae91d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>policy_id</th>\n",
       "      <th>policy</th>\n",
       "      <th>type</th>\n",
       "      <th>grade</th>\n",
       "      <th>reason</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>approved:0</td>\n",
       "      <td>TOTAL30® contact lenses that feel like nothing...</td>\n",
       "      <td>approved</td>\n",
       "      <td>20</td>\n",
       "      <td>Text 'good for eyes' is too vague and does not...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>approved:1</td>\n",
       "      <td>The first and only monthly replacement Water G...</td>\n",
       "      <td>approved</td>\n",
       "      <td>20</td>\n",
       "      <td>No mention of product uniqueness or monthly re...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>approved:2</td>\n",
       "      <td>TOTAL30® contact lenses feature a gradual tran...</td>\n",
       "      <td>approved</td>\n",
       "      <td>20</td>\n",
       "      <td>Text does not reference technical lens feature...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>approved:3</td>\n",
       "      <td>Water Gradient Technology in TOTAL30 contact l...</td>\n",
       "      <td>approved</td>\n",
       "      <td>20</td>\n",
       "      <td>No connection to technology durability or dura...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>approved:4</td>\n",
       "      <td>CELLIGENT® Technology creates a dynamic lens s...</td>\n",
       "      <td>approved</td>\n",
       "      <td>20</td>\n",
       "      <td>Text does not reference CELLIGENT technology o...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>approved:5</td>\n",
       "      <td>Helps resist the adherence of bacteria and lip...</td>\n",
       "      <td>approved</td>\n",
       "      <td>20</td>\n",
       "      <td>Text does not claim bacterial or lipid resista...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>approved:6</td>\n",
       "      <td>Water Gradient delivers superior softness and ...</td>\n",
       "      <td>approved</td>\n",
       "      <td>20</td>\n",
       "      <td>Text does not compare softness or lubricity to...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>approved:7</td>\n",
       "      <td>Class 1 UV Blocking delivers the highest level...</td>\n",
       "      <td>approved</td>\n",
       "      <td>20</td>\n",
       "      <td>No mention of UV blocking properties.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>approved:8</td>\n",
       "      <td>The first and only monthly replacement Water G...</td>\n",
       "      <td>approved</td>\n",
       "      <td>20</td>\n",
       "      <td>No mention of toric variant or uniqueness.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>approved:9</td>\n",
       "      <td>TOTAL30 delivers the only Water Gradient, reus...</td>\n",
       "      <td>approved</td>\n",
       "      <td>20</td>\n",
       "      <td>The text 'good for eyes' is too generic and do...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>fda:0</td>\n",
       "      <td>21 CFR § 886.5925(a): A soft (hydrophilic) con...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no conflict with vague marketing ph...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>fda:1</td>\n",
       "      <td>21 CFR § 886.5925(b)(1)-(2): Classification—Cl...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; marketing text does not address cla...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>fda:2</td>\n",
       "      <td>21 CFR § 886.5925(c): As of May 28, 1976, a PM...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; the text does not mention PMA or di...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>fda:3</td>\n",
       "      <td>21 CFR § 886.1(a): This part sets forth the cl...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; marketing text does not address cla...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>fda:4</td>\n",
       "      <td>21 CFR § 801.1(a): The label of a device in pa...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; does not address packaging or label...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>fda:5</td>\n",
       "      <td>21 CFR § 801.3: Definitions—includes, among ot...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no reference to UDI or device ident...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>fda:6</td>\n",
       "      <td>21 CFR § 801.5: Adequate directions for use me...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; vague claim does not provide direct...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>fda:7</td>\n",
       "      <td>21 CFR § 801.15(a): Required label information...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; marketing text does not discuss lab...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>fda:8</td>\n",
       "      <td>21 CFR § 801.18(a): Dates on device labels mus...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no mention of dates.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>fda:9</td>\n",
       "      <td>21 CFR § 801.109(c)-(d): Prescription devices—...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; text is a generic claim without lab...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>fda:10</td>\n",
       "      <td>21 CFR § 801.20(a)(1)-(2): The label of every ...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; does not address UDI requirements.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>fda:11</td>\n",
       "      <td>21 CFR § 801.45(a): A device required to bear ...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no UDI or reuse detailed.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>fda:12</td>\n",
       "      <td>21 CFR Part 830 (e.g., § 830.3): Establishes U...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no device identification content.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>fda:13</td>\n",
       "      <td>21 CFR § 830.310: GUDID data submission—labele...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; marketing text does not address dat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>fda:14</td>\n",
       "      <td>FDA UDI Compliance Dates: Labels and packages ...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no reference to label compliance.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>fda:15</td>\n",
       "      <td>21 CFR § 807.81: When a premarket notification...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; not discussing submissions.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>fda:16</td>\n",
       "      <td>21 CFR § 807.87: Information required in a pre...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no 510(k) information presented.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>fda:17</td>\n",
       "      <td>21 CFR § 807.92: Content and format of a 510(k...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no 510(k) summary content.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>fda:18</td>\n",
       "      <td>21 CFR § 807.97: Misbranding by reference to p...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no misbranding or reference to PMA ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>fda:19</td>\n",
       "      <td>21 CFR § 803.50(a): Manufacturer reporting—mus...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no reporting required.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>fda:20</td>\n",
       "      <td>21 CFR § 803.18(a): User facilities, importers...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no MDR event file content.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>fda:21</td>\n",
       "      <td>21 CFR Part 806 (§ 806.1): Manufacturers and i...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no correction or removal info.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>fda:22</td>\n",
       "      <td>21 CFR § 800.10(a)(1): All preparations intend...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no mention of solutions or preparat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>fda:23</td>\n",
       "      <td>21 CFR § 800.12: Contact lens solutions and ta...</td>\n",
       "      <td>fda</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; text does not discuss packaging or ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>ftc:0</td>\n",
       "      <td>§ 315.1: This part, which shall be called the ...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; marketing text does not address con...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>ftc:1</td>\n",
       "      <td>§ 315.2: “Business hours” means the prescriber...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no references to business hours or ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>ftc:2</td>\n",
       "      <td>§ 315.2: “Contact lens prescription” means a p...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; text does not mention prescriptions.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>ftc:3</td>\n",
       "      <td>§ 315.3(a)(1): When a prescriber completes a c...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no prescription or fitting process ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>ftc:4</td>\n",
       "      <td>§ 315.3(a)(2)-(3): The prescriber shall, as di...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no verification process mentioned.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>ftc:5</td>\n",
       "      <td>§ 315.3(b): A prescriber may not require the p...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no conditional purchasing or verifi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>ftc:6</td>\n",
       "      <td>§ 315.3(c)(1): Upon completion of a fitting, t...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no fitting completion or patient co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>ftc:7</td>\n",
       "      <td>§ 315.3(c)(3): A prescriber must maintain for ...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no mention of record retention or c...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>ftc:8</td>\n",
       "      <td>§ 315.4: A prescriber may require payment befo...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no payment or prescription release ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>ftc:9</td>\n",
       "      <td>§ 315.5(a): A seller may sell contact lenses o...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no sales or prescription verificati...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>ftc:10</td>\n",
       "      <td>§ 315.5(b): For verification, a seller shall p...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; does not address verification proto...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>ftc:11</td>\n",
       "      <td>§ 315.5(c)(3): Passive verification—prescripti...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no prescription timing or verificat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>ftc:12</td>\n",
       "      <td>§ 315.5(d): Automated telephone verification m...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no call or verification described.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>ftc:13</td>\n",
       "      <td>§ 315.5(e)-(f): If informed a prescription is ...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no prescription validity addressed.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>ftc:14</td>\n",
       "      <td>§ 315.6(a): A contact lens prescription shall ...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no prescription expiration mentioned.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>ftc:15</td>\n",
       "      <td>§ 315.7: No person may represent, by advertise...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>95</td>\n",
       "      <td>Text does not claim contact lenses can be obta...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>ftc:16</td>\n",
       "      <td>§ 315.8: A prescriber may not require a patien...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; marketing text does not address wai...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>ftc:17</td>\n",
       "      <td>§ 315.9: Any violation of this Rule shall be t...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; not deceptive or unfair.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>ftc:18</td>\n",
       "      <td>§ 255.1(a): Endorsements must reflect the hone...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>70</td>\n",
       "      <td>Text is a vague, non-specific claim; lacks sub...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>ftc:19</td>\n",
       "      <td>§ 255.2(b): If the advertiser does not have su...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no endorsement or consumer expectat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>ftc:20</td>\n",
       "      <td>§ 255.3(a): Expert endorsements must be suppor...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no expert endorsements.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>ftc:21</td>\n",
       "      <td>§ 255.4: Organizational endorsements shall be ...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no organizational endorsements.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>ftc:22</td>\n",
       "      <td>§ 255.5: When there exists a connection betwee...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no endorsements or connections.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>ftc:23</td>\n",
       "      <td>§ 255.6: Endorsements directed to children are...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>90</td>\n",
       "      <td>Unrelated; no endorsements directed to children.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>ftc:24</td>\n",
       "      <td>15 U.S.C. § 45(a)(1): Unfair methods of compet...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>75</td>\n",
       "      <td>Vague claim 'good for eyes' is not obviously d...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>ftc:25</td>\n",
       "      <td>15 U.S.C. § 52(a): It shall be unlawful for an...</td>\n",
       "      <td>ftc</td>\n",
       "      <td>75</td>\n",
       "      <td>Text 'good for eyes' could imply a health bene...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     policy_id                                             policy      type  \\\n",
       "0   approved:0  TOTAL30® contact lenses that feel like nothing...  approved   \n",
       "1   approved:1  The first and only monthly replacement Water G...  approved   \n",
       "2   approved:2  TOTAL30® contact lenses feature a gradual tran...  approved   \n",
       "3   approved:3  Water Gradient Technology in TOTAL30 contact l...  approved   \n",
       "4   approved:4  CELLIGENT® Technology creates a dynamic lens s...  approved   \n",
       "5   approved:5  Helps resist the adherence of bacteria and lip...  approved   \n",
       "6   approved:6  Water Gradient delivers superior softness and ...  approved   \n",
       "7   approved:7  Class 1 UV Blocking delivers the highest level...  approved   \n",
       "8   approved:8  The first and only monthly replacement Water G...  approved   \n",
       "9   approved:9  TOTAL30 delivers the only Water Gradient, reus...  approved   \n",
       "10       fda:0  21 CFR § 886.5925(a): A soft (hydrophilic) con...       fda   \n",
       "11       fda:1  21 CFR § 886.5925(b)(1)-(2): Classification—Cl...       fda   \n",
       "12       fda:2  21 CFR § 886.5925(c): As of May 28, 1976, a PM...       fda   \n",
       "13       fda:3  21 CFR § 886.1(a): This part sets forth the cl...       fda   \n",
       "14       fda:4  21 CFR § 801.1(a): The label of a device in pa...       fda   \n",
       "15       fda:5  21 CFR § 801.3: Definitions—includes, among ot...       fda   \n",
       "16       fda:6  21 CFR § 801.5: Adequate directions for use me...       fda   \n",
       "17       fda:7  21 CFR § 801.15(a): Required label information...       fda   \n",
       "18       fda:8  21 CFR § 801.18(a): Dates on device labels mus...       fda   \n",
       "19       fda:9  21 CFR § 801.109(c)-(d): Prescription devices—...       fda   \n",
       "20      fda:10  21 CFR § 801.20(a)(1)-(2): The label of every ...       fda   \n",
       "21      fda:11  21 CFR § 801.45(a): A device required to bear ...       fda   \n",
       "22      fda:12  21 CFR Part 830 (e.g., § 830.3): Establishes U...       fda   \n",
       "23      fda:13  21 CFR § 830.310: GUDID data submission—labele...       fda   \n",
       "24      fda:14  FDA UDI Compliance Dates: Labels and packages ...       fda   \n",
       "25      fda:15  21 CFR § 807.81: When a premarket notification...       fda   \n",
       "26      fda:16  21 CFR § 807.87: Information required in a pre...       fda   \n",
       "27      fda:17  21 CFR § 807.92: Content and format of a 510(k...       fda   \n",
       "28      fda:18  21 CFR § 807.97: Misbranding by reference to p...       fda   \n",
       "29      fda:19  21 CFR § 803.50(a): Manufacturer reporting—mus...       fda   \n",
       "30      fda:20  21 CFR § 803.18(a): User facilities, importers...       fda   \n",
       "31      fda:21  21 CFR Part 806 (§ 806.1): Manufacturers and i...       fda   \n",
       "32      fda:22  21 CFR § 800.10(a)(1): All preparations intend...       fda   \n",
       "33      fda:23  21 CFR § 800.12: Contact lens solutions and ta...       fda   \n",
       "34       ftc:0  § 315.1: This part, which shall be called the ...       ftc   \n",
       "35       ftc:1  § 315.2: “Business hours” means the prescriber...       ftc   \n",
       "36       ftc:2  § 315.2: “Contact lens prescription” means a p...       ftc   \n",
       "37       ftc:3  § 315.3(a)(1): When a prescriber completes a c...       ftc   \n",
       "38       ftc:4  § 315.3(a)(2)-(3): The prescriber shall, as di...       ftc   \n",
       "39       ftc:5  § 315.3(b): A prescriber may not require the p...       ftc   \n",
       "40       ftc:6  § 315.3(c)(1): Upon completion of a fitting, t...       ftc   \n",
       "41       ftc:7  § 315.3(c)(3): A prescriber must maintain for ...       ftc   \n",
       "42       ftc:8  § 315.4: A prescriber may require payment befo...       ftc   \n",
       "43       ftc:9  § 315.5(a): A seller may sell contact lenses o...       ftc   \n",
       "44      ftc:10  § 315.5(b): For verification, a seller shall p...       ftc   \n",
       "45      ftc:11  § 315.5(c)(3): Passive verification—prescripti...       ftc   \n",
       "46      ftc:12  § 315.5(d): Automated telephone verification m...       ftc   \n",
       "47      ftc:13  § 315.5(e)-(f): If informed a prescription is ...       ftc   \n",
       "48      ftc:14  § 315.6(a): A contact lens prescription shall ...       ftc   \n",
       "49      ftc:15  § 315.7: No person may represent, by advertise...       ftc   \n",
       "50      ftc:16  § 315.8: A prescriber may not require a patien...       ftc   \n",
       "51      ftc:17  § 315.9: Any violation of this Rule shall be t...       ftc   \n",
       "52      ftc:18  § 255.1(a): Endorsements must reflect the hone...       ftc   \n",
       "53      ftc:19  § 255.2(b): If the advertiser does not have su...       ftc   \n",
       "54      ftc:20  § 255.3(a): Expert endorsements must be suppor...       ftc   \n",
       "55      ftc:21  § 255.4: Organizational endorsements shall be ...       ftc   \n",
       "56      ftc:22  § 255.5: When there exists a connection betwee...       ftc   \n",
       "57      ftc:23  § 255.6: Endorsements directed to children are...       ftc   \n",
       "58      ftc:24  15 U.S.C. § 45(a)(1): Unfair methods of compet...       ftc   \n",
       "59      ftc:25  15 U.S.C. § 52(a): It shall be unlawful for an...       ftc   \n",
       "\n",
       "    grade                                             reason  \n",
       "0      20  Text 'good for eyes' is too vague and does not...  \n",
       "1      20  No mention of product uniqueness or monthly re...  \n",
       "2      20  Text does not reference technical lens feature...  \n",
       "3      20  No connection to technology durability or dura...  \n",
       "4      20  Text does not reference CELLIGENT technology o...  \n",
       "5      20  Text does not claim bacterial or lipid resista...  \n",
       "6      20  Text does not compare softness or lubricity to...  \n",
       "7      20              No mention of UV blocking properties.  \n",
       "8      20         No mention of toric variant or uniqueness.  \n",
       "9      20  The text 'good for eyes' is too generic and do...  \n",
       "10     90  Unrelated; no conflict with vague marketing ph...  \n",
       "11     90  Unrelated; marketing text does not address cla...  \n",
       "12     90  Unrelated; the text does not mention PMA or di...  \n",
       "13     90  Unrelated; marketing text does not address cla...  \n",
       "14     90  Unrelated; does not address packaging or label...  \n",
       "15     90  Unrelated; no reference to UDI or device ident...  \n",
       "16     90  Unrelated; vague claim does not provide direct...  \n",
       "17     90  Unrelated; marketing text does not discuss lab...  \n",
       "18     90                    Unrelated; no mention of dates.  \n",
       "19     90  Unrelated; text is a generic claim without lab...  \n",
       "20     90      Unrelated; does not address UDI requirements.  \n",
       "21     90               Unrelated; no UDI or reuse detailed.  \n",
       "22     90       Unrelated; no device identification content.  \n",
       "23     90  Unrelated; marketing text does not address dat...  \n",
       "24     90       Unrelated; no reference to label compliance.  \n",
       "25     90             Unrelated; not discussing submissions.  \n",
       "26     90        Unrelated; no 510(k) information presented.  \n",
       "27     90              Unrelated; no 510(k) summary content.  \n",
       "28     90  Unrelated; no misbranding or reference to PMA ...  \n",
       "29     90                  Unrelated; no reporting required.  \n",
       "30     90              Unrelated; no MDR event file content.  \n",
       "31     90          Unrelated; no correction or removal info.  \n",
       "32     90  Unrelated; no mention of solutions or preparat...  \n",
       "33     90  Unrelated; text does not discuss packaging or ...  \n",
       "34     90  Unrelated; marketing text does not address con...  \n",
       "35     90  Unrelated; no references to business hours or ...  \n",
       "36     90    Unrelated; text does not mention prescriptions.  \n",
       "37     90  Unrelated; no prescription or fitting process ...  \n",
       "38     90      Unrelated; no verification process mentioned.  \n",
       "39     90  Unrelated; no conditional purchasing or verifi...  \n",
       "40     90  Unrelated; no fitting completion or patient co...  \n",
       "41     90  Unrelated; no mention of record retention or c...  \n",
       "42     90  Unrelated; no payment or prescription release ...  \n",
       "43     90  Unrelated; no sales or prescription verificati...  \n",
       "44     90  Unrelated; does not address verification proto...  \n",
       "45     90  Unrelated; no prescription timing or verificat...  \n",
       "46     90      Unrelated; no call or verification described.  \n",
       "47     90     Unrelated; no prescription validity addressed.  \n",
       "48     90   Unrelated; no prescription expiration mentioned.  \n",
       "49     95  Text does not claim contact lenses can be obta...  \n",
       "50     90  Unrelated; marketing text does not address wai...  \n",
       "51     90                Unrelated; not deceptive or unfair.  \n",
       "52     70  Text is a vague, non-specific claim; lacks sub...  \n",
       "53     90  Unrelated; no endorsement or consumer expectat...  \n",
       "54     90                 Unrelated; no expert endorsements.  \n",
       "55     90         Unrelated; no organizational endorsements.  \n",
       "56     90         Unrelated; no endorsements or connections.  \n",
       "57     90   Unrelated; no endorsements directed to children.  \n",
       "58     75  Vague claim 'good for eyes' is not obviously d...  \n",
       "59     75  Text 'good for eyes' could imply a health bene...  "
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head(60)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b019afe6",
   "metadata": {},
   "outputs": [],
   "source": [
    "#get catagory scores\n",
    "approved_scores = df[df['type'] == 'approved']['grade']\n",
    "fda_scores = df[df['type'] == 'fda']['grade']\n",
    "ftc_scores = df[df['type'] == 'ftc']['grade']\n",
    "\n",
    "approved_score = approved_scores.max() if not approved_scores.empty else None\n",
    "\n",
    "def compute_category_score(df, category, threshold=70):\n",
    "    scores = df[df['type'] == category]['grade']\n",
    "\n",
    "    if scores.empty:\n",
    "        return 0\n",
    "    \n",
    "    base = scores.mean()\n",
    "    non_compliant_ratio = (scores < threshold).mean()\n",
    "    penalty = non_compliant_ratio * 100\n",
    "    \n",
    "    final = base - penalty\n",
    "    return max(0, min(100, final))  # clamp\n",
    "\n",
    "fda_score = compute_category_score(df, \"fda\")\n",
    "ftc_score = compute_category_score(df, \"ftc\")\n",
    "\n",
    "#Overall score is the average of the category scores\n",
    "category_scores = [score for score in [approved_score, fda_score, ftc_score] if score is not None] \n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
